Please click on the link to access the following documents.
Dengue
APBN White Paper Dengue and the Blood Supply (updated 2019)
This paper provides an overview of the threats and challenges posed by Dengue to the safety and sufficiency of the blood supply in the Asia-Pacific region, and offers mitigation and risk management strategies for consideration by blood services operating in the region. This updated version of the paper also includes reference to;
- vector control programs,
- the now available dengue vaccine,
- reports of additional transfusion acquired dengue infections,
- licensed RNA donor screening test availability, and
- additional references
Coronavirus (SARS-CoV-2)
APBN Rapid Brief White Paper 2019 Novel Coronavirus (SARS-CoV-2); Expected challenges and risks to blood safety
The 2019 novel coronavirus (SARS-CoV-2) which emerged in China presents a significant health threat in the Asia-Pacific region, and the ability to impact blood supply through donor deferrals, illness, quarantine and reduced staff or donor availability.
This paper outlines key challenges and risks to assist blood sector preparedness, response and implementation of appropriate risk reduction strategies.
